FDA OKs Stryker flow-diverting stent

|About: Stryker Corporation (SYK)|By:, SA News Editor

The FDA approves Stryker's (NYSE:SYK) Surpass Streamline Flow Diverter for the treatment of unruptured large and giant wide neck intracranial aneurysms. The small cobalt chromium braided stent directs blood flow within an intracranial artery away from a weakened blood vessel sac or aneurysm.

Subscribe for full text news in your inbox